Connection
Max Seibold to Biomarkers
This is a "connection" page, showing publications Max Seibold has written about Biomarkers.
|
|
Connection Strength |
|
 |
|
 |
|
0.195 |
|
|
|
-
Moore CM, Seibold MA. Possibilities and promise: Leveraging advances in?transcriptomics for clinical decision making in?allergic diseases. J Allergy Clin Immunol. 2022 10; 150(4):756-765.
Score: 0.102
-
Wesolowska-Andersen A, Seibold MA. Airway molecular endotypes of asthma: dissecting the heterogeneity. Curr Opin Allergy Clin Immunol. 2015 Apr; 15(2):163-8.
Score: 0.061
-
Coverstone AM, Seibold MA, Peters MC. Diagnosis and Management of T2-High Asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):442-450.
Score: 0.021
-
Innes AL, McGrath KW, Dougherty RH, McCulloch CE, Woodruff PG, Seibold MA, Okamoto KS, Ingmundson KJ, Solon MC, Carrington SD, Fahy JV. The H antigen at epithelial surfaces is associated with susceptibility to asthma exacerbation. Am J Respir Crit Care Med. 2011 Jan 15; 183(2):189-94.
Score: 0.011